News

Press Releases

Inflection Biosciences Announces Poster Presentation at the 2013 AACR-NCI-EORTC Conference

Dublin, Ireland, October 17, 2013 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...

Dr Michael O’Neill, Inflection Biosciences' Director of R&D interviewed by Pharma Television

Dublin, Ireland, 16 August 2013 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...

Inflection Licenses Preclinical Oncology Programs from the Spanish National Cancer Research Centre

Dublin, Ireland, June 4, 2013 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...

Inflection Biosciences Selected to Present at International Investor Forum

Dublin, Ireland, November 21, 2012 Inflection Biosciences limited was selected as one of 25 Irish companies to present at the 5th...

Inflection Biosciences to attend 24th Annual EORTC-NCI-AACR Symposium

Dublin, Ireland, November 6, 2012 Inflection Biosciences to attend the the 24th Annual EORTC-NCI-AACR Symposium on Molecular Targets and...